Robert James Wills Oncternal Therapeutics, Inc. (ONCT) insider trading activity

Robert James Wills is of Oncternal Therapeutics, Inc.. Currently has a direct ownership of 10,000 shares of ONCT, which is worth approximately $78,600. The most recent transaction as insider was on Apr 08, 2024, when has been sold 3,086 shares (Common Stock) at a price of $8.96 per share, resulting in proceeds of $27,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K

Infinity% 3M change

n/a 12M change

Total Value Held $78,600

Robert James Wills Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 08 2024	BUY Open market or private purchase	$27,650 $8.96 p/Share	3,086 Added 23.58%	10,000 Common Stock
Mar 28 2024	BUY Open market or private purchase	$58,630 $8.48 p/Share	6,914 Added 50.0%	6,914 Common Stock
Feb 23 2024	SELL Open market or private sale	$8,859 $9.04 p/Share	980 Reduced 100.0%	0 Common Stock

Also insider at

MIST

Milestone Pharmaceuticals Inc. Healthcare

Director

CBAY

CymaBay Therapeutics, Inc. Healthcare

RJW